Publication Name	World Journal of Gastroenterology
Manuscript ID	89054
Country	China

Received	2023-10-19 01:04
Peer-Review Started	2023-10-19 01:05
To Make the First Decision
Return for Revision	2024-01-31 06:45
Revised	2024-02-13 03:13
Second Decision	2024-04-22 02:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-04-22 04:50
Articles in Press	2024-04-22 04:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-29 16:08
Publish the Manuscript Online	2024-05-11 10:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Letter to the Editor
Article Title	Options and survival benefits of conversion therapy for unresectable hepatocellular carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Wong Hoi She and Tan To Cheung
ORCID	Author(s) ORCID Number Wong Hoi She http://orcid.org/0000-0003-2049-3140 Tan To Cheung http://orcid.org/0000-0002-2633-5883
Funding Agency and Grant Number
Corresponding Author	Tan To Cheung, MD, Professor, Department of Surgery, The University of Hong Kong, No. 102 Pok Fu Lam Road, Hong Kong , China. tantocheung@hotmail.com
Key Words	Conversion therapy; Immunotherapy; Liver resection; Survival; Transarterial chemoembolization; Unresectable hepatocellular carcinoma
Core Tip	In addition to transarterial chemoembolization (TACE), immunotherapy should also be among the options for conversion therapy for rendering unresectable hepatocellular carcinoma suitable for resection. For patients unsuitable for TACE, immunotherapy can be an alternative.
Publish Date	2024-05-11 10:58
Citation	<p>She WH, Cheung TT. Options and survival benefits of conversion therapy for unresectable hepatocellular carcinoma. <i>World J Gastroenterol</i> 2024; 30(18): 2479-2481</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i18/2479.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i18.2479

Full Article (PDF)	WJG-30-2479-with-cover.pdf
Manuscript File	89054_Auto_Edited-YJP.docx
Answering Reviewers	89054-Answering reviewers.pdf
Audio Core Tip	89054-Audio core tip.wav
Conflict-of-Interest Disclosure Form	89054-Conflict-of-interest statement.pdf
Copyright License Agreement	89054-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	89054-Language certificate.pdf
Peer-review Report	89054-Peer-review(s).pdf
Scientific Misconduct Check	89054-Bing-Qu XL-2.png
Scientific Editor Work List	89054-Scientific editor work list.pdf
CrossCheck Report	89054-CrossCheck report.pdf